Clinicopathological characteristics of primary Ki-1 anaplastic large cell lymphoma

International Journal of Hematology

Volumn 63, Issue 1, 1996, Pages 41-50

  Kobayashi, Toshitaka ^a   Nagasawa, Toshiro ^a   Mitsuhashi, Shoichi ^a   Hasegawa, Yuichi ^a   Kojima, Hiroshi ^a   Ninomiya, Haruhiko ^a   Mori, Naoyoshi ^b   Abe, Tsukasa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ESR; Ki 1 anaplastic large cell lymphoma; Poor prognosis; Skin involvement; globulin concentration

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CD30 ANTIGEN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; PIRARUBICIN; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SKIN TUMOR;

EID: 0030070221     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(95)00418-1     Document Type: Article

References (39)

1. Stein H, Mason DY, Gerdes J et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-858.
2. Kadin ME, Sako D, Berliner N et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986;68:1042-1049.
3. Schnitzer B, Roth MS, Hyder DM, Ginsburg D. Ki-1 lymphomas in children. Cancer 1988;61:1213-1221.
4. Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988;12:264-274.
5. Chan JKC, Ng CS, Hui PK et al. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 1989;15:11-34.
6. Piris M, Brown DC, Gatter KC, Mason DY. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990;17:211-218.
7. Banks PM, Metter J, Allred DC. Anaplastic large cell (Ki-1) lymphoma with histiocytic phenotype simulating carcinoma. Am J Clin Pathol 1990;94:445-452.
8. Carbone A, Gloghini A, Re VD, Tamaro P, Boiocchi M, Volpe R. Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer 1990;66:2547-2556.
9. O'Connor NTJ, Stein H, Gatter KC et al. Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 1987;11:733-740.
10. Herbst H, Tippelmann G, Anagnostopoulos I et al. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype. Leukemia Res 1989;13:103-116.
11. Shulman LN, Frisard B, Antin JH et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 1993;11:937-942.
12. Tashiro K, Kikuchi M, Takeshita M, Yoshida T, Ohshima K. Clinicopathological study of Ki-1-positive lymphomas. Path Res Pract 1989;185:461-467.
13. Bitter MA, Franklin WA, Larson RA et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;35). Am J Surg Pathol 1990;14:305-316.
14. Nakamura S, Takagi N, Kojima M et al. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 1991;68:118-129.
15. Kobayashi T, Nagasawa T, Abe T, Mori N. Morphological and immunohistochemical analysis of Ki-1 lymphoma. Jpn J Clin Hematol 1992;33:1183-1190 (in Japanese with English abstract).
16. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS. Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms. Cancer 1991;68:362-373.
17. Pearson JM, Borg-Grech A. Primary Ki-1 (CD30)-positive, large cell, anaplastic lymphoma of the esophagus. Cancer 1991;68:418-421.
18. Greer JP, Kinney MC, Collins RD et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991;9:539-547.
19. Fujimoto J, Hata J, Ishii E et al. Ki-1 lymphoma in childhood: Immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Archiv A 1988;412:307-314.
20. Kamesaki H, Miwa H, Ohno Y et al. A novel B cell line established from Ki-1 positive diffuse large cell lymphoma. Jpn J Cancer Res 1988; 79: 1193-1200.
21. Kaneko Y, Frizzera G, Edamura S et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989;73:806-813.
22. Ohshima K, Kikuchi M, Masuda Y et al. Genotypic and immunophenotypic analysis of anaplastic large cell lymphoma (Ki-1 lymphoma). Path Res Pract 1990;186: 582-588.
23. Agematsu K, Takeuchi S, Ichikawa M et al. Spontaneous production of interleukin-6 by Ki-1-positive large-cell anaplastic lymphoma with extensive bone destruction. Blood 1991;77:2299-2303.
24. Nishihira H, Tanaka Y, Kigasawa H, Sasaki Y, Fujimoto J. Ki-1 lymphoma producing G-CSF. Br J Haematol 1991;80:556-565.
25. Tsukamoto N, Monta K, Maehara T et al. Ki-1-positive large-cell anaplastic lymphoma with protean manifestations including central nervous system involvement. Acta Haematol 1992;88:147-150.
26. Tsurumi H, Takahashi T, Moriwaki H, Muto Y. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease. Int J Hematol 1992;56:99-102.
27. Miyazono M, Iwaki T, Tateishi J, Fukui M. Anaplastic large cell Ki-1 lymphoma in the central nervous system: Report of an autopsy case. Acta Neuropathol 1992;84:577-580.
28. X expression in CD30-positive anaplastic large-cell lymphoma. J Cancer Res Clin Oncol 1992;119:87-90.
29. Mori N, Yatabe Y, Oka K et al. Primary gastric Ki-1 positive anaplastic large cell lymphoma: A report of two cases. Pathol Int 1994;44:164-169.
30. Miyake K, Yoshino T, Sarker AB, Teramoto N, Akagi T. CD30 antigen in non-Hodgkin's lymphoma. Pathol Int 1994;44:428-434.
31. Akamatsu M, Takeshita M, Ohshima K, Kikuchi M, Suzumiya J. Analysis of adhesion molecules in Ki-1 anaplastic large-cell lymphoma. Virchows Archiv 1994;425:33-39.
32. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992;68: 421-427.
33. Smith CA, Davis T, Anderson D et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-1023.
34. Smith CA, Davis T, Wignall J et al. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun 1991;176:335-342.
35. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology of TNF. Cell 1993;73:1349-1360.
36. Schwab U, Stein H, Gerdes J et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982;299:65-67.
37. Leoncini L, Del Vecchio MT, Kraft R et al. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - A continuous spectrum of maligant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 1990;137:1047-1057.
38. Pileri S, Bocchia M, Baroni CD et al. Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective clinico-pathological study of 69 cases. Br J Haematol 1994;86:513-523.
39. Salhany KE, Collins RD, Greer JP, Kinney MC. Long-term survival in Ki-1 lymphoma. Cancer 1991;67: 516-522.